Current COVID-19 boosters provide protections against serious infection: study
Despite the evolution of the SARS-CoV-2 pandemic coronavirus, a new laboratory study conducted by a team of international researchers suggests current vaccine boosters may elicit sufficient immune protection against severe omicron-induced COVID-19 disease. Read More
Researchers target protein to hasten search for next COVID-19 antiviral
A new approach to identifying molecules that interfere with the protein nsp13 could speed up the search for the next COVID-19 antiviral and lead to development of pan-coronavirus antivirals. Read More
Bruker launches new assay for long COVID syndrome
Bruker debuted its PhenoRisk PACS RuO, a research use only nuclear magnetic resonance test for molecular phenomics research on long COVID patients’ blood samples. Read More
NIH study shows how immune response to COVID-19 damages the brain
A National Institutes of Health (NIH) study, which examined brain changes in nine people who died suddenly after contracting COVID-19, found that antibodies are involved in the attack on cells lining the brain's blood vessels, leading to inflammation and damage. Read More
Triggering memory B cells directly in lungs seen as way to improve vaccines
How can the efficacy of vaccines used to protect against viral respiratory diseases such as influenza and COVID-19 be increased? The triggering of memory B cells directly in the lungs could be a promising method, according to scientists. Read More
PrecisionLife, Sano Genetics partner on studying long COVID
PrecisionLife is joining forces with Sano Genetics to better understand the long-term effects of the coronavirus (long COVID). PrecisionLife’s proprietary combinatorial analytics platform will identify risk factors and potential drug targets by analyzing Sano Genetics’ data from 3,000 U.K. adults suffering from long COVID symptoms. Read More
How has the COVID-19 pandemic affected pediatric care?
What impact has the COVID-19 pandemic had on the care of pediatric cancer patients internationally? It depends on the country, according to Dr. Muhammed Elhadi of the University of Tripoli in Libya. Elhadi spoke with ScienceBoard.net at the recent American Association for Cancer Research meeting in New Orleans. Read More
CoVac-1 vaccine shows promise for immunocompromised patients
At the recent American Association for Cancer Research meeting in New Orleans, ScienceBoard.net spoke with the University of Tübingen’s Dr. Juliane Walz, professor of peptide-based immunotherapies, and research associate Claudia Tandler about the promising results their CoVac-1 vaccine has shown in immunocompromised patients. Read More
COVID-19 protects unvaccinated from reinfection
Unvaccinated people who have a previous COVID-19 infection have a level of protection from future infections that's comparable to protection provided by mRNA vaccines, according to a new study published on April 20 in JAMA Network Open. Read More
Moderna Charitable Foundation awards $5M in initial grants
Biotechnology company Moderna has announced the launch of the Moderna Charitable Foundation. Approximately $5 million in initial grants have been awarded to local and global nonprofits that support groups and causes disproportionately affected by COVD-19. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter